Tacrolimus ointment for the treatment of steroid-induced rosacea: A preliminary report

Journal of the American Academy of Dermatology

Volumn 44, Issue 6, 2001, Pages 995-998

  Goldman, David ^a  

^a Department of Dermatology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIINFLAMMATORY AGENT; CAFFEINE; CORTICOSTEROID; FLUORIDE; MACROLIDE; TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIET RESTRICTION; DISEASE COURSE; ERYTHEMA; FEMALE; HUMAN; MALE; OINTMENT; PRELIMINARY COMMUNICATION; PRIORITY JOURNAL; PRURITUS; ROSACEA; TREATMENT OUTCOME;

EID: 0035013932     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2001.114739     Document Type: Article

References (12)

1. Adverse effect of topical fluorinated corticosteroids in rosacea
2. Steroid rosacea
3. Eyelid dermatitis to red face syndrome to cure: Clinical experience in 100 cases
4. Cardiovascular regulatory mechanisms
5. The microcirculation and lymphatics
6. Facial blanching caused by superpotent cortcosteroids
7. Atopic dermatitis: New insights and opportunities for therapeutic intervention
8. Seborrheic dermatitis, psoriasis, recalcitrant palmoplantar eruptions, pustular dermatitis, and erythroderma
9. Tacrolimus: The drug for the turn of the millennium?
10. Biochemical and immunologic mechanisms in atopic dermatitis: New targets for emerging therapies
11. Tacrolimus (FK506) ointment for atopic dermatitis: A phase I study in adults and children